Complete remission · minimal change disease in adults with nephrotic syndrome
Mycophenolate sodium + oral steroids showed no clear difference in complete remission Time frame: 4 weeks compared with oral steroids alone (moderate certainty).
2 findings from 1 review
Complete or partial remission · minimal change disease in adults with nephrotic syndrome
Mycophenolate sodium + oral steroids showed no clear difference in complete or partial remission Time frame: 24 weeks to end of treatment compared with oral steroids alone (moderate certainty).
1 finding from 1 review
Relapse · minimal change disease in adults with nephrotic syndrome
Mycophenolate sodium + oral steroids showed no clear difference in relapse Time frame: 24 weeks compared with oral steroids alone (low certainty).
1 finding from 1 review
Adverse events: death · minimal change disease in adults with nephrotic syndrome
Mycophenolate sodium + oral steroids showed no clear difference in adverse events: death compared with oral steroids alone (low certainty).
1 finding from 1 review
Acute kidney injury · minimal change disease in adults with nephrotic syndrome
Mycophenolate sodium + oral steroids showed no clear difference in adverse events: acute kidney injury compared with oral steroids alone (low certainty).
1 finding from 1 review
Adverse events: new‐onset glucose intolerance · minimal change disease in adults with nephrotic syndrome
Mycophenolate sodium + oral steroids showed no clear difference in adverse events: new‐onset glucose intolerance compared with oral steroids alone (low certainty).
1 finding from 1 review
Relapse · minimal change disease in adults with nephrotic syndrome
It is very uncertain whether steroids changes relapse during compared with no specific treatment (very low certainty).
1 finding from 1 review
Adverse events: avascular necrosis · minimal change disease in adults with nephrotic syndrome
It is very uncertain whether steroids changes adverse events: avascular necrosis compared with no specific treatment (very low certainty).
1 finding from 1 review
Doubling serum creatinine · minimal change disease in adults with nephrotic syndrome
It is very uncertain whether steroids changes adverse events: doubling serum creatinine compared with no specific treatment (very low certainty).
1 finding from 1 review
Adverse events: kidney failure · minimal change disease in adults with nephrotic syndrome
It is very uncertain whether steroids changes adverse events: kidney failure compared with no specific treatment (very low certainty).
1 finding from 1 review
Complete remission · minimal change disease in adults with nephrotic syndrome
It is very uncertain whether intravenous ± oral steroids changes complete remission Time frame: 2 to 28 months compared with oral steroids alone (very low certainty).
1 finding from 1 review
Complete or partial remission · minimal change disease in adults with nephrotic syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse · minimal change disease in adults with nephrotic syndrome
It is very uncertain whether intravenous ± oral steroids changes relapse during compared with oral steroids alone (very low certainty).
1 finding from 1 review
Intervention not reported
Mobilityd ‐ overall analysis Using different mobility scales: MILA (range 0 to 36), EMS (range 0 to 20), BBS (range 0 to 56), PPME (range 0 to 12), Koval (range 1 to 7). Higher values indicate better mobility (except MILA and Koval, where scale wa... · adults following hip fracture surgery
The intervention may leads to higher mobilityd ‐ overall analysis Using different mobility scales: MILA… (low certainty).
1 finding from 1 review
Intervention not reported
Mobility scales, using EMS (range 0 to 20). Higher values indicate better mobility · adults following hip fracture surgery
The intervention showed no clear difference in mobility scales, using EMS (range 0 to 20). Higher values indicate… (low certainty).
1 finding from 1 review
Intervention not reported
TUG (lower score = faster) · adults following hip fracture surgery
The intervention showed no clear difference in TUG (lower score = faster) (low certainty).
1 finding from 1 review
Intervention not reported
Mobilityd ‐ overall analysis Using different mobility scales: mPPT (range 0 to 36), POMA (range 0 to 30), SPPB (range 0 to 12), PPME (range 0 to 12). A higher score indicates better mobility. · adults following hip fracture surgery
The intervention leads to higher mobilityd ‐ overall analysis Using different mobility scales: mPPT… (high certainty).
1 finding from 1 review
Intervention not reported
Walking speedg ‐ overall analysis Measured using metres/second (m/s) and metres/minute (m/min). A higher score indicates faster walking. · adults following hip fracture surgery
The intervention leads to higher walking speedg ‐ overall analysis Measured using metres/second (m/s)… (high certainty).
1 finding from 1 review
Intervention not reported
Functioningi ‐ overall analysis Using different functioning scales: FSQ (range 0 to 36), BI (range 0 to 100), AM‐PAC daily activity (range 9 to 101), COPM (range 0 to 20), LEFS (range 0 to 80), NEADL (range 0 to 66). A higher score indicates bette... · adults following hip fracture surgery
The intervention leads to higher functioningi ‐ overall analysis Using different functioning scales:… (high certainty).
1 finding from 1 review
Intervention not reported
HRQoL using EQ‐ 5D (range 0 to 1), SF‐36 (range 0 to 100), SF‐12 (range 0 to 100), and WHOQOL‐BREF (range 0 to 130). A higher score indicates better quality of life. · adults following hip fracture surgery
The intervention showed no clear difference in HRQoL using EQ‐ 5D (range 0 to 1), SF‐36 (range 0 to 100), SF‐12… (moderate certainty).
1 finding from 1 review